alpha-aminopyridine has been researched along with Proteus Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Biesecker, LG; de Moya, AJ; Hodges, MB; Ours, CA; Sapp, JC | 1 |
| Abbadessa, G; Collins, CD; Crown, J; Fagotti, A; Gullo, G; Kazakin, J; Leoni, C; Onesimo, R; Ranieri, C; Resta, N; Scambia, G; Schwartz, B; Zampino, G | 1 |
| Biesecker, LG; Ferrari, D; Lindhurst, MJ; Savage, RE; Yourick, MR; Yu, Y | 1 |
3 other study(ies) available for alpha-aminopyridine and Proteus Syndrome
| Article | Year |
|---|---|
Case report: five-year experience of AKT inhibition with miransertib (MK-7075) in an individual with Proteus syndrome.
Topics: Aminopyridines; Humans; Imidazoles; Male; Proteus Syndrome; Proto-Oncogene Proteins c-akt | 2021 |
First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma.
Topics: Adolescent; Aminopyridines; Female; Humans; Imidazoles; Mutation; Ovarian Neoplasms; Protein Kinase Inhibitors; Proteus Syndrome; Proto-Oncogene Proteins c-akt | 2019 |
Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome.
Topics: Aminopyridines; Becaplermin; Cell Survival; Cells, Cultured; Humans; Imidazoles; Mutation; Phosphorylation; Protein Kinase Inhibitors; Proteus Syndrome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-sis; Signal Transduction | 2015 |